Therapeutic targets for triple negative breast cancer: development of mono and bispecific antibodies against Notch1 ligands

Prize: Fellowship awarded competitively

Description

Therapeutic targets for triple negative breast cancer: development of mono and bispecific antibodies against Notch1 ligands Therapeutic targets for triple negative breast cancer: development of mono and bispecific antibodies against Notch1 ligands”, Collaborator, FCT-MCTES, PTDC/BBB-BMD/4497/2014
Awarded date1 Jan 2016
Granting OrganisationsFundação para a Ciência e a Tecnologia

    Fingerprint